Review Article
A Network Meta-Analysis of Two Doses of Recombinant Human Thrombopoietin for Treating Sepsis-Related Thrombocytopenia
Figure 6
Network meta-analysis of the relative efficacy and the rank probabilities among different treatment strategies in terms of the level of platelet on the 7th day (a), transfusion of RBC (b), transfusion of plasma (c), and transfusion of platelets (d). NAT, no additional treatment; IVIG, intravenous immunoglobulin; rhTPO 300, 300 U/kg/d recombinant human thrombopoietin; rhTPO 15000, 15000 U/d recombinant human thrombopoietin.
| (a) |
| (b) |
| (c) |
| (d) |